Form FDA 483 · Issued 2026-01-30
QPS, LLC — FDA Form 483 Analysis
FEI: 3003581184 · Sector: Pharmaceuticals & Sterile/OTC Drugs (Biopharmaceutics Analytical Facility) · Lead Investigator: Elena R. Rostova
FDA Form 483 issued to QPS, LLC (FEI 3003581184) on 2026-01-30 following an inspection of its biopharmaceutics analytical facility operations in Delaware. The report documents 3 inspection observations centered on Finished Product Testing, Stability & Expiration Dating, Master Manufacturing & Batch Production Records (MMR/BPR).
Get Full Annotated 483 Dossier + CAPA Checklist
Instant PDF + CFR Matrix ($79 vs. Redica's $289)
Need Help Fixing These 3 Citations?
Get matched with a vetted 21 CFR remediation consultant
Observation-by-Observation 21 CFR Breakdown (3)
Observation #1 · 21 CFR 211.166(b)
Finished Product Testing, Stability & Expiration Dating
FIRST-TIME OBSERVATION
Accelerated stability studies
Inspector Observation Language: "Accelerated stability studies, combined with basic stability information, used to support tentative expiration dates are not supported with ongoing full shelf life studies. Specifically, observed during inspection of QPS, LLC on 2026-01-30."
Plain-English Meaning: Releasing finished batches without verifying strength/potency/microbiological specs, or placing an expiration/best-by date on labels without supporting real-time or accelerated stability data.
Standard CAPA Remediation Path: Require finished-batch microbiological (USP <2021>/<2022>), heavy metal, and active-assay release testing plus ICH stability chamber protocols supporting every label shelf-life claim.
Observation #2 · 21 CFR 211.188(b)(7)
Master Manufacturing & Batch Production Records (MMR/BPR)
REPEAT CITATION AT FACILITY
Documentation of Actual Yield and Theoretical Yield
Inspector Observation Language: "The batch production and control records are deficient in that they do not include a statement of the [actual yield] [percentage of theoretical yield]. Specifically, observed during inspection of QPS, LLC on 2026-01-30."
Plain-English Meaning: Missing Master Manufacturing Records (MMRs) or incomplete Batch Production Records (BPRs) lacking exact component weights, lot numbers, yield reconciliation, or second-person verification.
Standard CAPA Remediation Path: Ensure every product SKU has an approved MMR matching the exact label claim and every batch record captures raw material lot traceability, in-process weight/pH checks, and QA release signatures.
Observation #3 · 21 CFR 211.194(d)
Finished Product Testing, Stability & Expiration Dating
FIRST-TIME OBSERVATION
Laboratory equipment calibration records
Inspector Observation Language: "Laboratory records do not include complete records of the periodic calibration of laboratory [instruments] [apparatus] [gauges] [recording devices]. Specifically, observed during inspection of QPS, LLC on 2026-01-30."
Plain-English Meaning: Releasing finished batches without verifying strength/potency/microbiological specs, or placing an expiration/best-by date on labels without supporting real-time or accelerated stability data.
Standard CAPA Remediation Path: Require finished-batch microbiological (USP <2021>/<2022>), heavy metal, and active-assay release testing plus ICH stability chamber protocols supporting every label shelf-life claim.